Abstract
In the December 2013 issue of Nucleic Acid Therapeutics, (vol 23, no. 6; 369–378) “Characterization of Target mRNA Reduction Through In Situ RNA Hybridization in Multiple Organ Systems Following Systemic Antisense Treatment in Animals” the Author Disclosure Statement incorrectly read “No competing financial interests exist.” It should have read “All authors are employees and stockholders of Isis Pharmaceuticals, Inc.”
The online version of this article has been corrected.